Detalhe da pesquisa
1.
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas.
Hematol Oncol
; 41(3): 571-573, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319789
2.
IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling.
Proc Natl Acad Sci U S A
; 117(8): 4320-4327, 2020 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32047037
3.
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.
Br J Haematol
; 198(1): 103-113, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277855
4.
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.
Blood
; 135(15): 1244-1254, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32006000
5.
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia.
Haematologica
; 106(9): 2345-2353, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732360
6.
SF3B1-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation
Haematologica
; 106(12): 3125-3135, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121237
7.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378569
8.
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.
Haematologica
; 105(4): 1042-1054, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289209
9.
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.
Haematologica
; 105(6): 1613-1620, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582547
10.
Intravascular Colonization of Kaposi Sarcoma: Expanding the Spectrum of Specific Infiltrates of B-Cell Chronic Lymphocytic Leukemia.
Am J Dermatopathol
; 41(12): 940-944, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268930
11.
COVID-19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients.
Hematol Oncol
; 41(3): 559-562, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585917
12.
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.
Am J Hematol
; 98(7): E157-E160, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067157
13.
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.
Am J Hematol
; 98(2): E24-E27, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349541
14.
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.
Blood
; 126(16): 1921-4, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26276669
15.
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study.
Haematologica
; 107(6): 1470-1473, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199505
16.
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Am J Hematol
; 92(6): 529-535, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295527
17.
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model.
Am J Hematol
; 97(5): E176-E180, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170793
18.
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
Haematologica
; 101(1): 77-85, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26565002
19.
COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
Hematol Oncol
; 39(5): 712-714, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462939
20.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol
; 39(4): 570-574, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258787